Ticker
IPSCCompany Name
CENTURY THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -21.51M | -18.85% | $ 114.13M |
3/31/2025 | $ -20.16M | -17.54% | $ 114.9M |
12/31/2024 | $ -124.78M | -1893.7% | $ 6.59M |
9/30/2024 | $ -130.75M | -4869.53% | $ 2.69M |
6/30/2024 | $ -131.64M | -6446.67% | $ 2.04M |
3/31/2024 | $ -132.66M | -9683.28% | $ 1.37M |
12/31/2023 | $ -134.25M | -6006.8% | $ 2.23M |
9/30/2023 | $ -125.22M | -5033.04% | $ 2.49M |
6/30/2023 | $ -123.44M | -2704.75% | $ 4.56M |
3/31/2023 | $ -121.88M | -2079.51% | $ 5.86M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for CENTURY THERAPEUTICS INC is calculated as follows: EBIT [ $ -53.19M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]
Minimum
Mar 31, 2022
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.54% |
median | 9.01% |
std | 23.96% |